Skip to content

Based on my review of the GO-CAM model gomodel:662af8fa00002877 and related research materials, here is my assessment:

GO-CAM Review: TRAIL/TRAILR1 interaction leading to apoptosis (gomodel:662af8fa00002877)

Overview of the Model

The GO-CAM model gomodel:662af8fa00002877 titled "TRAIL/TRAILR1 interaction leading to apoptosis" describes the TRAIL-activated apoptotic signaling pathway mediated through TRAIL receptor 1 (DR4/TNFRSF10A) and the subsequent molecular events leading to apoptosis.

Model Structure and Content

The model captures the following key components:

  1. TNFSF10 (TRAIL) with cytokine activity in the extracellular space
  2. TNFRSF10A (DR4) with signaling receptor activity in plasma membrane rafts
  3. ZDHHC3 with palmitoyltransferase activity in the Golgi apparatus
  4. TRADD with protein-macromolecule adaptor activity in the cytoplasm
  5. FADD with protein-macromolecule adaptor activity in the cytoplasm
  6. CASP8 with cysteine-type endopeptidase activity in the cytoplasm

The causal connections are well-organized, representing the flow of information: 1. TRAIL → DR4 2. DR4 → TRADD 3. TRADD → FADD 4. FADD → CASP8

Scientific Accuracy Assessment

The model is scientifically accurate and supported by current literature. Key molecular mechanisms represented include:

  1. DR4 Palmitoylation: The model correctly represents ZDHHC3's role in palmitoylating DR4, which is critical for its proper plasma membrane localization and function (supported by PMIDs 19090789, 22240897, 21926431).

  2. TRAIL Receptor Specificity: The model focuses correctly on the DR4/TRAIL-R1 pathway which has specific regulatory mechanisms distinct from DR5/TRAIL-R2 (supported by PMID 22240897).

  3. Death-Inducing Signaling Complex (DISC) Formation: The sequential recruitment of TRADD, FADD, and caspase-8 is correctly represented.

  4. Membrane Localization: The inclusion of DR4 localization to membrane rafts is well-supported by literature showing this is essential for efficient signaling.

Strengths of the Model

  1. Molecular Specificity: The model accurately represents the specific role of DR4/TRAIL-R1 rather than combining DR4 and DR5 pathways, which is appropriate given their different regulatory mechanisms.

  2. Post-translational Modifications: The inclusion of ZDHHC3-mediated palmitoylation of DR4 represents an important regulatory mechanism well-supported by literature.

  3. Subcellular Localization: The model correctly includes subcellular localization information, which is crucial for understanding the mechanism of this pathway.

  4. Evidence Quality: The model uses high-quality evidence with appropriate ECO codes, primarily based on direct assays (ECO:0000314) and author statements with traceable support (ECO:0000303).

Suggestions for Improvement

  1. Death Domain Interactions: Consider adding more detail about the specific death domain interactions between DR4, TRADD, and FADD, as these are critical for DISC formation.

  2. Caspase-8 Activation: The model could be extended to show caspase-8 activation and its downstream effects, including the cleavage of effector caspases like caspase-3.

  3. Membrane Dynamics: Given the importance of rafts in DR4 signaling, consider adding information about the role of membrane dynamics in TRAIL-DR4 signaling.

  4. Regulatory Mechanisms: Consider adding inhibitory mechanisms or feedback loops that regulate this pathway, such as FLIP inhibition of caspase-8 activation.

Compliance with GO-CAM Guidelines

The model follows GO-CAM best practices:

  1. Molecular Functions: All activities are correctly assigned with appropriate GO terms.

  2. Causal Relationships: The "directly positively regulates" (RO:0002629) relationship is properly used throughout the model.

  3. Evidence Codes: Appropriate evidence codes with PMIDs are provided for each assertion.

  4. Cellular Components: Proper localization is provided for each activity.

  5. Biological Process Context: All activities are correctly assigned to the "TRAIL-activated apoptotic signaling pathway" (GO:0036462).

Conclusion

The GO-CAM model gomodel:662af8fa00002877 effectively represents the current understanding of TRAIL/TRAIL-R1 signaling leading to apoptosis, with special emphasis on the role of palmitoylation in DR4 function. The model is well-structured, supported by high-quality evidence, and follows GO-CAM best practices. The few suggested additions would enhance the model by providing more detailed mechanisms without changing its essential accuracy.